SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-013104
Filing Date
2023-04-17
Accepted
2023-04-17 17:04:06
Documents
18

Document Format Files

Seq Description Document Type Size
1 PRE 14A vktx-20230417.htm   iXBRL PRE 14A 1126512
2 GRAPHIC img253239293_0.jpg GRAPHIC 398611
3 GRAPHIC img253239293_1.jpg GRAPHIC 358396
4 GRAPHIC img253239293_2.jpg GRAPHIC 83779
5 GRAPHIC img253239293_3.jpg GRAPHIC 122829
  Complete submission text file 0000950170-23-013104.txt   3922658

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vktx-20230417_pre.xml EX-101.PRE 9079
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vktx-20230417.xsd EX-101.SCH 6267
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vktx-20230417_lab.xml EX-101.LAB 15040
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vktx-20230417_def.xml EX-101.DEF 7402
12 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20230417_htm.xml XML 171931
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37355 | Film No.: 23824640
SIC: 2834 Pharmaceutical Preparations